Debra Weese-Mayer
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Debra Weese-Mayer sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Debra Weese-Mayer: 3 sponsored US clinical trials, 3 recruiting.
Debra Weese-Mayer sponsors 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Congenital Central Hypoventilation Syndrome, with 2 trials.
Upper-quartile sponsor footprint
Debra Weese-Mayer sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
NCT03568669
International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
NCT03088020
International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry
NCT03135730
Therapeutic Areas
What is open in the Debra Weese-Mayer pipeline
3 recruiting of 3 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Congenital Central Hypoventilation Syndrome (2 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Debra Weese-Mayer: open-pipeline peers nationwide
Peers matched on 3 registered trials and 100% open enrollment, not the therapeutic-area sidebar.
Debra Weese-Mayer sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 100% open enrollment (± trial volume)
- AAVantgarde Bio Srl · 100% recruiting · 2 trials
- Acorn Biolabs · 100% recruiting · 3 trials
- Acrivon Therapeutics · 100% recruiting · 2 trials
- ADARx Pharmaceuticals · 100% recruiting · 4 trials
Related
What to do with this Debra Weese-Mayer page
3 registered trials is a research-attention snapshot, not an endorsement of Debra Weese-Mayer or any single study.
- 3 of Debra Weese-Mayer's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Central Hypoventilation Syndrome is the condition Debra Weese-Mayer studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Central Hypoventilation Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Debra Weese-Mayer pipeline card: 3 registered trials from official public datasets.Report a data error.